These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30273713)

  • 21. [Red blood cell production for transfusion purposes. A stem cell ex vivo fate].
    Mazurier C; Douay L
    Transfus Clin Biol; 2013 May; 20(2):90-4. PubMed ID: 23601197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice.
    Deng J; Lancelot M; Jajosky R; Deng Q; Deeb K; Saakadze N; Gao Y; Jaye D; Liu S; Stowell SR; Cheng L; Roback JD
    Am J Hematol; 2022 Feb; 97(2):194-202. PubMed ID: 34779029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.
    Peyrard T; Bardiaux L; Krause C; Kobari L; Lapillonne H; Andreu G; Douay L
    Transfus Med Rev; 2011 Jul; 25(3):206-16. PubMed ID: 21377319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly Defined Induced Pluripotent Stem Cell Lines Mimic Donor Red Blood Cell Antigen Profiles for Therapeutic and Diagnostic Use.
    Catelli LF; Mendes da Costa PN; Rós FA; Rodrigues ES; Ursoli FF; Santos FLS; Dorigan M; de Castilho LM; Covas DT; Kashima S
    Cell Reprogram; 2024 Jun; 26(3):107-115. PubMed ID: 38917437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research advances on directional induction and differentiation in vitro from human pluripotent stem cells into erythrocytes].
    Liu SQ; Zhang LF; Wang YB; Huang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):213-8. PubMed ID: 24598681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concise review: stem cell-based approaches to red blood cell production for transfusion.
    Shah S; Huang X; Cheng L
    Stem Cells Transl Med; 2014 Mar; 3(3):346-55. PubMed ID: 24361925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of Baboon (
    Olivier EN; Wang K; Grossman J; Mahmud N; Bouhassira EE
    Cells; 2019 Oct; 8(10):. PubMed ID: 31635069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of red blood cells from induced pluripotent stem cells.
    Gunawardena N; Chou ST
    Curr Opin Hematol; 2024 May; 31(3):115-121. PubMed ID: 38362913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro production of transfusable red blood cells.
    Nakamura Y
    Biotechnol Genet Eng Rev; 2008; 25():187-201. PubMed ID: 21412356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human mesenchymal stem cells promote CD34
    Lau SX; Leong YY; Ng WH; Ng AWP; Ismail IS; Yusoff NM; Ramasamy R; Tan JJ
    Cell Biol Int; 2017 Jun; 41(6):697-704. PubMed ID: 28403524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells.
    Giarratana MC; Kobari L; Lapillonne H; Chalmers D; Kiger L; Cynober T; Marden MC; Wajcman H; Douay L
    Nat Biotechnol; 2005 Jan; 23(1):69-74. PubMed ID: 15619619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells.
    Giani FC; Fiorini C; Wakabayashi A; Ludwig LS; Salem RM; Jobaliya CD; Regan SN; Ulirsch JC; Liang G; Steinberg-Shemer O; Guo MH; Esko T; Tong W; Brugnara C; Hirschhorn JN; Weiss MJ; Zon LI; Chou ST; French DL; Musunuru K; Sankaran VG
    Cell Stem Cell; 2016 Jan; 18(1):73-78. PubMed ID: 26607381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?
    Douay L; Andreu G
    Transfus Med Rev; 2007 Apr; 21(2):91-100. PubMed ID: 17397760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cultured blood versus donated blood: long-run perspectives of the economy of blood.
    Mercier Ythier J
    Biomed Mater Eng; 2015; 25(1 Suppl):199-209. PubMed ID: 25538070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells.
    Ju H; Sohn Y; Nam Y; Rim YA
    Stem Cell Res Ther; 2024 May; 15(1):142. PubMed ID: 38750578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo generation of human red blood cells: a new advance in stem cell engineering.
    Douay L; Giarratana MC
    Methods Mol Biol; 2009; 482():127-40. PubMed ID: 19089353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definitive Erythropoiesis from Pluripotent Stem Cells: Recent Advances and Perspectives.
    Demirci S; Tisdale JF
    Adv Exp Med Biol; 2018; 1107():1-13. PubMed ID: 29876866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells.
    Pavani G; Klein JG; Nations CC; Sussman JH; Tan K; An HH; Abdulmalik O; Thom CS; Gearhart PA; Willett CM; Maguire JA; Chou ST; French DL; Gadue P
    Blood Adv; 2024 Mar; 8(6):1449-1463. PubMed ID: 38290102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes.
    Park YJ; Jeon SH; Kim HK; Suh EJ; Choi SJ; Kim S; Kim HO
    J Transl Med; 2020 Jun; 18(1):236. PubMed ID: 32532292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic use of red blood cells and platelets derived from human cord blood stem cells.
    Xie X; Yao H; Han X; Yue W; Pei X
    Stem Cells Transl Med; 2021 Nov; 10 Suppl 2(Suppl 2):S48-S53. PubMed ID: 34724719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.